文献速递肿瘤 PET/CT

18F-FDG摄取在化生性乳腺癌中优于68Ga-FAP-2286

18 F-FDG Uptake Outperforms 68 Ga-FAP-2286 in Metaplastic Breast Carcinoma.
PubMed 文献 · Clin Nucl Med · 2026-03-23

本文报告一例47岁女性化生性乳腺癌伴间叶分化及肺和淋巴结转移的病例,比较18F-FDG PET/CT与68Ga-FAP-2286 PET/CT的显像表现,发现原发灶和转移灶对18F-FDG的摄取均显著高于68Ga-FAP-2286。

要点

  • 化生性乳腺癌常呈三阴性表型,诊断和治疗具有挑战性。
  • 本例原发灶及转移灶的18F-FDG摄取明显高于68Ga-FAP-2286。
  • 18F-FDG PET/CT在该病例的显像中表现更优。

核心结论

  • 在化生性乳腺癌伴间叶分化及转移的病例中,18F-FDG PET/CT的示踪剂摄取显著高于68Ga-FAP-2286 PET/CT。

研究设计与样本

  • 病例报告:一例47岁女性化生性乳腺癌伴间叶分化及肺和淋巴结转移。

主要发现

  • 原发灶和转移灶在18F-FDG PET/CT上的示踪剂摄取均显著高于相应的68Ga-FAP-2286 PET/CT。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metaplastic breast carcinoma is a rare, aggressive malignancy that most commonly exhibits a triple-negative phenotype; its clinical, pathologic, and imaging diagnosis can be challenging, and treatment outcomes and prognosis are generally poor. Here, we report the discrepant imaging findings on 18 F-FDG PET/CT and 68 Ga-FAP-2286 PET/CT in a 47-year-old woman with metaplastic carcinoma of the breast with mesenchymal differentiation and pulmonary and lymph node metastases: tracer uptake in both the primary lesion and metastatic sites was markedly higher on 18 F-FDG PET/CT than on the corresponding 68 Ga-FAP-2286 PET/CT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhang N, Liu W, Jiang L, et al. 18 F-FDG Uptake Outperforms 68 Ga-FAP-2286 in Metaplastic Breast Carcinoma. Clin Nucl Med. 2026. PMID: 41940823. doi:10.1097/RLU.0000000000006413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。